Clinical Trials Browser

Phase 3 × perifosine × Plasma cell × Clear all

NCT01002248 2018-02-09

Assessment of Efficacy and Safety of Perifosine, Bortezomib and Dexamethasone in Multiple Myeloma Patients

Phase 3 Terminated

Multiple Myeloma